Molecular Culture
Financiado
World’s first diagnostic test that can detect all bacterial species in a single...
Every year, bacterial infections cause 20% of human deaths. These deaths can be avoided only if the patients are administered correct medical treatment without any delays. Today, the diagnostic tests used to detect and identify ba...
Every year, bacterial infections cause 20% of human deaths. These deaths can be avoided only if the patients are administered correct medical treatment without any delays. Today, the diagnostic tests used to detect and identify bacteria are too slow or not comprehensive enough. Often, doctors have no other option, but to administer treatment through antibiotics based on educated guesswork which can lead to medical complications, in addition to increased patient care costs. To address these issues, Inbiome is developing a cost-effective diagnostic test called Molecular Culture which detects and identifies all bacterial species with 100% accuracy and delivers results within 4 hours. During the EIC project, Inbiome will perform an implementation trial of Molecular Culture in a live hospital setting, optimizing the interface for hospital workflows, clinical validation of additional sample types, adding Anti-Microbial Resistance testing in the workflow, and expanding commercial skills.
ver más
Duración del proyecto: 24 meses
Fecha Inicio: 2023-08-15
Fecha Fin: 2025-08-31
Fecha Fin: 2025-08-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-08-15
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIC-2023-ACCELERATOROPEN-01:
EIC Accelerator Open 2023
Cerrada
hace 1 año
Presupuesto
El presupuesto total del proyecto asciende a
5M€
Líder del proyecto
INBIOME BV
No se ha especificado una descripción o un objeto social para esta compañía.
